版本:
中国

BRIEF-La Jolla Pharmaceutical Co announces proposed underwritten public offering of common stock

March 20 La Jolla Pharmaceutical Co

* La Jolla Pharmaceutical Company announces proposed underwritten public offering of common stock

* La Jolla Pharmaceutical Co - announced its intention to offer and sell $100 million of its common stock in an underwritten public offering

* La Jolla Pharmaceutical Co - intends to use net proceeds from underwritten offering for future clinical trials of its drug candidates, among others Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐